Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
The combination may produce additive microbiome benefits, though this has not been formally studied
GLP-1s can be a powerful tool, but theyre probably most effective when paired with sustainable habitsand for many people, they may work best as a long-term treatment rather than a short-term kickstart
With our Weight Loss Program , you can see if you might be eligible, understand your options, and visualize what your weight loss could look like while tracking your progress over time
2 And those were Phase 2 numbers Phase 3 results came in even higher